1. Home
  2. MRUS vs ATHM Comparison

MRUS vs ATHM Comparison

Compare MRUS & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • ATHM
  • Stock Information
  • Founded
  • MRUS 2003
  • ATHM 2008
  • Country
  • MRUS Netherlands
  • ATHM China
  • Employees
  • MRUS N/A
  • ATHM N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • ATHM EDP Services
  • Sector
  • MRUS Health Care
  • ATHM Technology
  • Exchange
  • MRUS Nasdaq
  • ATHM Nasdaq
  • Market Cap
  • MRUS 3.6B
  • ATHM 3.3B
  • IPO Year
  • MRUS 2016
  • ATHM 2013
  • Fundamental
  • Price
  • MRUS $43.19
  • ATHM $27.86
  • Analyst Decision
  • MRUS Strong Buy
  • ATHM Hold
  • Analyst Count
  • MRUS 12
  • ATHM 2
  • Target Price
  • MRUS $87.92
  • ATHM $28.00
  • AVG Volume (30 Days)
  • MRUS 650.3K
  • ATHM 501.8K
  • Earning Date
  • MRUS 10-31-2024
  • ATHM 02-04-2025
  • Dividend Yield
  • MRUS N/A
  • ATHM 6.17%
  • EPS Growth
  • MRUS N/A
  • ATHM N/A
  • EPS
  • MRUS N/A
  • ATHM 2.02
  • Revenue
  • MRUS $35,932,000.00
  • ATHM $1,021,825,075.00
  • Revenue This Year
  • MRUS N/A
  • ATHM $0.03
  • Revenue Next Year
  • MRUS $61.42
  • ATHM $1.14
  • P/E Ratio
  • MRUS N/A
  • ATHM $13.92
  • Revenue Growth
  • MRUS N/A
  • ATHM 0.02
  • 52 Week Low
  • MRUS $22.75
  • ATHM $21.89
  • 52 Week High
  • MRUS $61.61
  • ATHM $34.70
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 37.90
  • ATHM 47.49
  • Support Level
  • MRUS $41.63
  • ATHM $27.71
  • Resistance Level
  • MRUS $45.83
  • ATHM $30.88
  • Average True Range (ATR)
  • MRUS 2.35
  • ATHM 0.91
  • MACD
  • MRUS -0.10
  • ATHM 0.14
  • Stochastic Oscillator
  • MRUS 19.97
  • ATHM 30.89

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market in 2019.

Share on Social Networks: